RxDoctor Payments Data

Drew Miller, MD

Family Medicine · Lakin, KSNPI 1487859625

Payments from drug & device makers

$541in general payments, 2019–2025

Across 35 payments — averaging $15.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$146
  • Novo Nordisk$144
  • Lilly USA, LLC$92
  • Orthofix Medical, Inc.$47
  • Sanofi-aventis U.S. LLC$37
  • Mylan Specialty L.p.$29
  • plus $47 from 3 others

What the payments were for

  • Food & beverage$541100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$541 in reported general payments places this provider in the 50th percentile of 1,469 family medicine providers in Kansas.

See all family medicine providers in Kansas

Medicare billing

Part B allowed, 2024
$9,360
Medicare patients
43
Services billed
350

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide95$105,124
Soliqua 100-33Insulin Glargine/Lixisenatide36$57,195
EliquisApixaban76$46,217
XareltoRivaroxaban73$39,220
Synjardy XrEmpagliflozin/Metformin Hcl26$31,006
Trelegy ElliptaFluticasone/Umeclidin/Vilanter41$26,066
Droxidopa12$25,975
LinzessLinaclotide32$25,965
Xultophy 100-3.6Insulin Degludec/Liraglutide17$23,215
JardianceEmpagliflozin16$22,844
Xigduo XrDapaglifloz Propaned/Metformin38$21,721
FarxigaDapagliflozin Propanediol11$17,708
Breztri AerosphereBudesonide/Glycopyr/Formoterol26$16,944
MounjaroTirzepatide16$16,383
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr30$15,871

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Xultophy 100-3.6$144$128,340112 claims
Sanofi-aventis U.S. LLCSoliqua 100-33$37$57,19536 claims
AstraZenecaFarxiga, Breztri Aerosphere, Symbicort$146$39,13751 claims
Lilly USA, LLCMounjaro$92$16,38316 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 1,469 family medicine providers in Kansas.

Other family medicine in Lakin

See the full list for Kansas

Where these figures come from

Is this you, or does something look wrong? →